bluebird bio-Bluebird Bio (BLUE) Reports Q4 Loss, Tops Revenue Estimates

Bluebird Bio (BLUE) came out with a quarterly loss of $23.74 per share versus the Zacks Consensus Estimate of a loss of$ 6.60. This compares to loss of $15.60 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -259.70%. A quarter ago, it was expected that this biotechnology company would post a loss of$ 7.60 per share when it actually produced a loss of $6.20, delivering a surprise of 18.42%.Over the last four quarters, the compa ...